Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DOTAP provides a permanent positive charge that significantly improves transfection in hard-to-transfect cell types.59,60,61”
From Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles (2026) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · cited 2×
“Compared to DNA, although mRNA is less stable, it causes fewer immune responses (2).”
BackgroundOpportunities and Challenges in the Delivery of mRNA-Based Vaccines
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584 · cited 1×
“Moreover, since mRNA is directly delivered and expressed in the cytoplasm without requiring nuclear localization for expression, there is no potential for mutagenesis due to genomic integration (14, 15).”
Background
Research works printed but not linked: 36
- Nayerossadat N, Maedeh T, Ali PA. Viral and nonviral delivery systems for gene delivery. Adv Biomed Res. 2012;1:27. · DOI · Paper page
- Gjetting T, Arildsen NS, Christensen CL, Poulsen TT, Roth JA, Handlos VN, et al. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection. Int J Nanomed. 2010;5:371–83.
- Kawano T, Okuda T, Aoyagi H, Niidome T. Long circulation of intravenously administered plasmid DNA delivered with dendritic poly(L-lysine) in the blood flow. Journal of controlled release : official journal of the Controlled Release Society. 2004;99(2):329–37. · DOI
- Zhao Y, Wang W, Guo S, Wang Y, Miao L, Xiong Y, et al. PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery. Nat Commun. 2016;7(1):11822. · DOI · Paper page
- Kim S-Y, Lee S-J, Lim S-J. Formulation and in vitro and in vivo evaluation of a cationic emulsion as a vehicle for improving adenoviral gene transfer. Int J Pharm. 2014;475(1):49–59. · doi:10.1016/j.ijpharm.2014.08.024
- Vupputuri S, Tayebi L, HikkaduwaKoralege RS, Nigatu A, Mozafari M, Mishra A, et al. Polyethylene glycol–modified DOTAP:cholesterol/adenovirus hybrid vectors have improved transduction efficiency and reduced immunogenicity. J Nanopart Res. 2021;23(2):37. · DOI
- Xu L, Anchordoquy TJ. Cholesterol domains in cationic lipid/DNA complexes improve transfection. Biochimica et Biophysica Acta (BBA) Biomembranes. 2008;1778(10):2177–81. · DOI
- Köster F, Finas D, Schulz C, Hauser C, Diedrich K, Felberbaum R. Additive effect of steroids and cholesterol on the liposomal transfection of the breast cancer cell line T-47D. Int J Mol Med. 2004;14(4):769–72.
- Templeton NS. Nonviral delivery for genomic therapy of cancer. World J Surg. 2009;33(4):685–97. · DOI
- Gao Q, Dong X, Luo Y, Zhang G, Shan J, Wang Q, et al. Construction of human MASP-2-CCP1/2SP, CCP2SP, SP plasmid DNA nanolipoplexes and the effects on tuberculosis in BCG-infected mice. Microb Pathog. 2017;109:200–8. · doi:10.1016/j.micpath.2017.05.043
- Shen L, Li J, Liu Q, Song W, Zhang X, Tiruthani K, et al. Local blockade of interleukin 10 and C-X-C motif chemokine ligand 12 with nano-delivery promotes antitumor response in murine cancers. ACS Nano. 2018;12(10):9830–41. · DOI
- Sicard G, Paris C, Giacometti S, Rodallec A, Ciccolini J, Rocchi P, et al. Enhanced antisense oligonucleotide delivery using cationic liposomes grafted with trastuzumab: a proof-of-concept study in prostate cancer. Pharmaceutics. 2020;12(12):1166. · DOI
- Brégeon D, Doetsch PW. Transcriptional mutagenesis: causes and involvement in tumour development. Nat Rev Cancer. 2011;11(3):218–27. · DOI · Paper page
- Sun M, Yuan Y, Lu F, Di Pasqua AJ. Physicochemical factors that influence the biocompatibility of cationic liposomes and their ability to deliver DNA to the nuclei of ovarian cancer SK-OV-3 cells. Materials (Basel). 2021;14(2):416. · DOI
- Yang SY, Zheng Y, Chen JY, Zhang QY, Zhao D, Han DE, et al. Comprehensive study of cationic liposomes composed of DC-Chol and cholesterol with different mole ratios for gene transfection. Colloids Surf, B. 2013;101:6–13. · doi:10.1016/j.colsurfb.2012.05.032
- Wu Y, Sun J, Li A, Chen D. The promoted delivery of RRM2 siRNA to vascular smooth muscle cells through liposome-polycation-DNA complex conjugated with cell penetrating peptides. Biomed Pharmacother. 2018;103:982–8. · DOI
- Roberts R, Al-Jamal WT, Whelband M, Thomas P, Jefferson M, van den Bossche J, et al. Autophagy and formation of tubulovesicular autophagosomes provide a barrier against nonviral gene delivery. Autophagy. 2013;9(5):667–82. · DOI · Paper page
- Tao J, Ding WF, Che XH, Chen YC, Chen F, Chen XD, et al. Optimization of a cationic liposome-based gene delivery system for the application of miR-145 in anticancer therapeutics. Int J Mol Med. 2016;37(5):1345–54. · DOI
- Inglut CT, Sorrin AJ, Kuruppu T, Vig S, Cicalo J, Ahmad H, et al. Immunological and toxicological considerations for the design of liposomes. Nanomaterials (Basel). 2020;10(2):190. · DOI · Paper page
- Hosseini ES, Nikkhah M, Hosseinkhani S. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9. Int J Nanomed. 2019;14:4353–66. · DOI
- Zhang Y, Li H, Sun J, Gao J, Liu W, Li B, et al. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Int J Pharm. 2010;390(2):198–207. · DOI
- Brgles M, Šantak M, Halassy B, Forcic D, Tomašić J. Influence of charge ratio of liposome/DNA complexes on their size after extrusion and transfection efficiency. Int J Nanomed. 2012;7:393–401. · DOI
- Elsana H, Olusanya TOB, Carr-wilkinson J, Darby S, Faheem A, Elkordy AA. Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems. Sci Rep. 2019;9(1):15120. · DOI · Paper page
- Psaras AM, Chang KT, Hao T, Brooks TA. Targeted downregulation of MYC through G-quadruplex stabilization by DNAi. Molecules. 2021;26(18):5542. · DOI
- Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, et al. Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS ONE. 2012;7(4): e34833. · DOI · Paper page
- Junquera E, Aicart E. Recent progress in gene therapy to deliver nucleic acids with multivalent cationic vectors. Adv Coll Interface Sci. 2016;233:161–75. · DOI
- Garbuzenko O, Barenholz Y, Priev A. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem Phys Lipids. 2005;135(2):117–29. · DOI · Paper page
- Tang J, Kuai R, Yuan W, Drake L, Moon JJ, Schwendeman A. Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting. Nanomedicine. 2017;13(6):1869–78. · DOI
- Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577–91. · DOI · Paper page
- Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem. 1994;269(4):2550–61. · DOI · Paper page
- Belmadi N, Midoux P, Loyer P, Passirani C, Pichon C, Le Gall T, et al. Synthetic vectors for gene delivery: an overview of their evolution depending on routes of administration. Biotechnol J. 2015;10(9):1370–89. · DOI
- Zuhorn IS, Bakowsky U, Polushkin E, Visser WH, Stuart MC, Engberts JB, et al. Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Molecular therapy : the journal of the American Society of Gene Therapy. 2005;11(5):801–10. · DOI · Paper page
- Kim SY, Lee SJ, Kim JK, Choi HG, Lim SJ. Optimization and physicochemical characterization of a cationic lipid-phosphatidylcholine mixed emulsion formulated as a highly efficient vehicle that facilitates adenoviral gene transfer. Int J Nanomed. 2017;12:7323–35. · DOI
- Xu L, Anchordoquy TJ. Cholesterol domains in cationic lipid/DNA complexes improve transfection. Biochem Biophys Acta. 2008;1778(10):2177–81. · DOI
- Kumru OS, Joshi SB, Smith DE, Middaugh CR, Prusik T, Volkin DB. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals. 2014;42(5):237–59. · DOI · Paper page
- Kaddah S, Khreich N, Kaddah F, Charcosset C, Greige-Gerges H. Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2018;113:40–8. · DOI · Paper page
Cited by
Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles
Ramamurthy, A., Scimonelli, G., Murphy, W. L., & Saha, K. (2026) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2026.103081
Metadata
- Authors
- Sun, M., Dang, U. J., Yuan, Y., Psaras, A. M., Osipitan, O., Brooks, T. A., Lu, F., & Di Pasqua, A. J.
- Venue
- AAPS PharmSciTech
- Published
- 2022-05-09
- Volume
- 23
- Issue
- 5
- ISSN
- 1530-9932
- Cited by
- 67
- References
- 3
- Language
- en
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery. https://app.cochat.ai/papers/10.1208/s12249-022-02294-w
- The paper
- Sun, M., Dang, U. J., Yuan, Y., Psaras, A. M., Osipitan, O., Brooks, T. A., Lu, F., & Di Pasqua, A. J. (2022). Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery. AAPS PharmSciTech. https://doi.org/10.1208/s12249-022-02294-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.